News Novartis expands virtual clinical trial project with Science... Swiss pharma builds on existing collaboration with Science 37
News Celgene to tackle 'undruggable' targets with Vividion Celgene has signed a deal with Vividion Therapeutics to develop drugs for oncology, inflammatory, and neurodegenerative diseases.
News Breath Biopsy company adds new investor to $15m fundraising Owlstone Medical, the innovative company which promises to revolutionise the diagnosis of cancer by simply analysing a patient's breath has been given a major funding boost.
News NHS drug deal could fund vital cystic fibrosis research - Ve... Vertex wants long-term funding for CF research
News Mylan to develop Botox biosimilar with Revance Mylan takes aim at Allergan's off-patent blockbuster
News Tesaro and Roche to combine drugs in bladder cancer trials Tesaro is to combine its PARP-inhibitor drug Zejula with Roche’s PD-L1 immunotherapy Tecentriq in clinical trials for metastatic bladder cancer.
News CHMP backs Novo's haemophilia A drug Frehemgo Novo has moved a step closer to EU approval of its long-acting haemophilia A therapy, Frehemgo, which could be a future blockbuster.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
